Key facts
- Notable investors include Gobi Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ailsynbio
- ·The full record, as it builds
Funding rounds
No funding rounds for Ailsynbio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ailsynbio
Developer of synthetic biology solutions designed to replace chemical disinfectants and enhance health outcomes. The company harnesses beneficial microbes to create next-generation biotechnologies that improve human well-being and environmental sustainability.
- Sector
- Healthcare
- HQ
- Hong Kong, Hong Kong
- Founded
- 2025
- Website
- ailsynbio.com/
- Ownership
- Privately Held (backing)
Ailsynbio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ailsynbio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ailsynbio in its N-PORT filings yet. We sweep new filings monthly.